Jinquan Dong

Title: **Innovator Spotlight: Jinquan Dong**

Introduction

Jinquan Dong is a notable inventor based in Stoneham, Massachusetts, who has made significant contributions to the field of pharmaceuticals. He holds a patent for a unique controlled release dosage form aimed at treating specific diseases, including multiple sclerosis. His innovation reflects his commitment to advancing medical science and improving patient care.

Latest Patents

Jinquan Dong's patent is titled "Controlled release dosage form for once daily administration of dimethyl fumarate." This invention involves a controlled release dosage form that contains monomethyl fumarate or its pharmaceutically acceptable salts, which can be metabolized into monomethyl fumarate in vivo. The patent emphasizes a method for treating diseases by administering the controlled release dosage form orally, thereby enhancing the therapeutic effectiveness and convenience for patients.

Career Highlights

Currently, Jinquan Dong is associated with Biogen MA Inc., a leading biotechnology company focused on developing therapies for neurological diseases. His work at Biogen includes research and development in innovative treatment modalities that address complex medical conditions. Dong's patent underscores his expertise in the pharmaceutical industry and his role as a forward-thinking inventor.

Collaborations

In his career, Jinquan Dong has collaborated with esteemed colleagues such as Peter Zawaneh and Shyam B Karki. These collaborations reflect a dynamic team environment where innovative ideas can flourish, contributing to the advancement of medical technology and patient treatment options.

Conclusion

Jinquan Dong exemplifies the spirit of innovation in the pharmaceuticals field. His patented technology for a controlled release dosage form represents a significant advancement in how specific diseases can be treated effectively. With a commitment to research and collaboration, Dong continues to contribute to the biopharmaceutical landscape, and his work holds promise for improving the lives of many patients suffering from chronic conditions.